The Cholangiocarcinoma Foundation

International Cholangiocarcinoma Research Network (ICRN)

The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma.

The goal of ICRN is to accelerate the clinical translation of scientific discoveries to impact the lives of patients with cholangiocarcinoma.

Upcoming Events

Asia Pacific Conference

Event details:

March 15-16, 2019 – Taipei, Taiwan

About the Conference:

The 3rd Annual Asia-Pacific Cholangiocarcinoma Conference is where interested individuals come together to learn about the latest research advances for the prevention, diagnosis, treatment, and a cure for cholangiocarcinoma. More than 300 multidisciplinary professional attendees will gather the most up-to-date information through basic science, translational and clinical research sessions, along with many networking opportunities.

Chairs:

Dr. Li Tzong Chen, National Institute of Cancer Research, TaiwanDr. Flavio G Rocha, Virginia Mason Medical Center, USA

Co-Chairs:

1. Cholangiocarcinoma Foundation

2. Taiwan Cooperative Oncology Group

3. Taiwan Oncology Society

4. The Gastroenterological Society of Taiwan

5. The Digestive Endoscopy Society of Taiwan

6. Taiwan Surgical Society of Gastroenterologyn

Why Attend:

The 2019 Conference gives you the opportunity to collaborate with international key opinion leaders advancing cholangiocarcinoma research, treatment and care.

Industry Forum:

For information about presenting your early-stage clinical concepts to the International Cholangiocarcinoma Research Network for the purposes of feedback and collaboration, please contact Kathi.Wagner@cholangiocarcinoma.org or call 630-286-0418.

Call for Posters

ICRN Newsletters

Issue 1: July 2017

Issue 2: January 2018

Issue 3: May 2018

ICRN Members Map

If your industry or biotech company or organization is interested in partnering with the ICRN for the purposes of cholangiocarcinoma research and potential collaboration, please fill out the ICRN Industry Request for Engagement form.

ICRN Executive Committee

Milind Javle, MD

Chair

UT MD Anderson Cancer Center

Mitesh Borad, MD

Vice Chair

Mayo Clinic, Arizona

John Bridgewater, PhD

University College London Hospital, UK

Yun Shin Chun, MD, FACS

MD Anderson

Laura Goff, MD

Vanderbilt Ingram Cancer Center

Lipika Goyal, MD

Massachusetts General Hospital/Harvard University

Stacie Lindsey

Cholangiocarcinoma Foundation

Shishir K. Maithel, MD, FACS

Emory University

Lewis Roberts, MB, ChB, PhD

Mayo Clinic, Minnesota

Flavio Rocha, MD, FACS

Virginia Mason Medical Center

Virote Sriuranpong, MD, PhD

Chulalongkorn University

The ICRN and CCF are here to help!

CCF and the ICRN are here to help support your research and clinical trial efforts to benefit patients with cholangiocarcinoma. Please contact kathi.wagner@cholangiocarcinoma.org if you would like information regarding:

Posting any trial open to cca patients (including baskets, pan-tumor, solid tumor, etc.) on CCF’s website and social media
Hosting a patient education webinar about your trial
Assistance with clinical validation of your agent in cholangiocarcinoma (IST’s, multi-institutional collaborations)
Assistance with pre-clinical validation of your agent in cholangiocarcinoma (access to cca cell lines, PDX models, tissues samples, etc.)
Patient Advisory Boards
Industry Forum presentation opportunities to 50+ KOL’s
US and Asia-Pacific Poster, Exhibit and Sponsorship opportunities
Patient and caregiver speakers and advocates
Telecons with KOL’s to discuss trial design and protocols
and more